Altimmune, Inc. (ALT) › Total LiabilitiesAltimmune, Inc. (ALT) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $14.99M2011: $6.95M2012: $11.07M2013: $9.80M2014: $3.70M2015: $3.21M2016: $6.19M2017: $14.35M2018: $6.44M2019: $8.54M2020: $19.24M2021: $19.73M2022: $21.64M2023: $16.54M2024: $15.80M2025: $55.04M$55.04M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$55.04M+248.4%2024$15.80M-4.5%2023$16.54M-23.5%2022$21.64M+9.7%2021$19.73M+2.6%2020$19.24M+125.3%2019$8.54M+32.6%2018$6.44M-55.1%2017$14.35M+131.8%2016$6.19M+92.7%2015$3.21M-13.3%2014$3.70M-62.2%2013$9.80M-11.4%2012$11.07M+59.2%2011$6.95M-53.6%2010$14.99M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share